Terapia periodontal não cirúrgica para redução de riscos cardiovasculares em pacientes com síndrome metabólica: revisão da literatura integrativa

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Referências

Bartold PM, Dyke TEV. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 2013;62(1):203-17.

Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care 1993;16(1):329-34.

Albandar JM, Susin C, Hughes FJ. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: case definitions and diagnostic considerations. J Clin Periodontol 2018;45(suppl.20):171s-89s.

Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20(2):12.

Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leitão CB, Gross JL et al. Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res 2018;32:e35.

Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res 2007;86(3):271-5.

D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani AD, Deanfield J et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab 2008;93(10):3989-94.

Jaramillo A, Contreras A, Lafaurie GI, Duque A, Ardila CM, Duarte S et al. Association of metabolic syndrome and chronic periodontitis in Colombians. Clin Oral Investig 2017;21(5):1537-44.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [On-line]. Disponível em <http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>. Acesso em: 10-12-2020.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.

López NJ, Quintero A, Casanova PA, Ibieta CI, Baelum V, López R. Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol 2012;83(3):267-78.

Bizzarro S, van der Velden U, Teeuw WJ, Gerdes VEA, Loos BG. Effect of periodontal therapy with systemic antimicrobials on parameters of metabolic syndrome: a randomized clinical trial. J Clin Periodontol 2017;44(8):833-41.

Montero E, López M, Vidal H, Martínez M, Virto L, Marrero J et al. Impact of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a randomized clinical trial [On-line]. Disponível em <https://doi.org/10.1111/dom.14131>. Acesso em: 15-7-2020.

Acharya A, Bhavsar N, Jadav B, Parikh H. Cardioprotective effect of periodontal therapy in metabolic syndrome: a pilot study in Indian subjects. Metab Syndr Relat Disord 2010;8(4):335-41.

Torumtay G, Kırzıoğlu FY, Öztürk Tonguç M, Kale B, Calapoğlu M, Orhan H. Effects of periodontal treatment on inflammation and oxidative stress markers in patients with metabolic syndrome. J Periodontal Res 2016;51(4):489-98.

Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds 2017;11(8):215-25.

Babio N, Toledo E, Estruch R, Ros E, Martínez-González MA, Castañer O et al. Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ 2014;186(17):649-57.

Cozlea DL, Farcas DM, Nagy A, Keresztesi AA, Tifrea R, Cozlea L et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J 2013;39(4):225-31.

D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84(3):269-73.

Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74(8):1231-6.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78.

Kikui M, Kokubo Y, Ono T, Kida M, Kosaka T, Yamamoto M et al. Relationship between metabolic syndrome components and periodontal disease in a Japanese general population: the suita study. J Atheroscler Thromb 2017;24(5):495-507.

Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune AN et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol 2017;109(2 suppl.1):1-76.

Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 2000;71(8):1375-84.

Saito M, Shimazaki Y, Nonoyama T, Tadokoro Y. Number of teeth, oral self-care, eating speed, and metabolic syndrome in an aged Japanese population. J Epidemiol 2019;29(1):26-32.

Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N et al. A cohort study on the association between periodontal disease and the development of metabolic syndrome. J Periodontol 2010;81(4):512-9.

Salvi GE, Franco LM, Braun TM, Lee A, Rutger Persson G, Lang NP et al. Pro-inflammatory biomarkers during experimental gingivitis in patients with type 1 diabetes mellitus: a proof-of-concept study. J Clin Periodontol 2010;37(1):9-16.

Preshaw PM, Alba AL, Herrera D, Jepsen S, Konstantinidis A, Makrilakis K et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012;55(1):21-31.

Peng CH, Yang YS, Chan KC, Kornelius E, Chiou JY, Huang CN. Periodontal treatment and the risks of cardiovascular disease in patients with type 2 diabetes: a retrospective cohort study. Intern Med 2017;56(9):1015-21.

Teshome A, Yitayeh A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: systematic review and meta-analysis. BMC Oral Health 2016;17(1):31.

Sgolastra F, Gatto R, Petrucci A, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 2012;83(10):1257-69.

Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol 2020;47(suppl.22):257-81.

Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 2014;15(4):277-87.

Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000 2017;75(1):317-29.

Lang NP, Bartold PM. Periodontal health. J Periodontol 2018;89(suppl.1): S9-S16.